Form 4 Filing for Peter C. Farrell - Arcturus Therapeutics Holdings Inc.

Peter C. Farrell, a director at Arcturus Therapeutics Holdings Inc. (ARCT), acquired 15,000 stock options on June 5, 2026. The options have an exercise price of $7.30 and expire on June 5, 2036. These options are part of the 2026 annual grant to Mr. Farrell for his role as a Board member. The shares underlying the option vest monthly over a one-year period from the grant date. Mr. Farrell, who is not an officer or ten percent owner, reported this transaction on Form 4, with the filing signed on June 15, 2026. The transaction is marked as direct ownership.